<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142775</url>
  </required_header>
  <id_info>
    <org_study_id>ChariteMM</org_study_id>
    <nct_id>NCT04142775</nct_id>
  </id_info>
  <brief_title>Predictors of Intracranial Hemorrhage in ARDS Patients on ECMO</brief_title>
  <official_title>Predictors of Intracranial Hemorrhage in Critically Ill Patients With Acute Lung Failure (ARDS) on Extracorporeal Membrane Oxygenation (ECMO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intracranial hemorrhage is is a rare, but critical incident in patients with acute lung
      failure undergoing ECMO therapy. Predictors of intracranial hemorrhage are yet to be defined
      to identify patients at (high) risk. This retrospective analysis investigates the predictive
      value and validity of parameters and specific risk factors of critically ill ARDS patients
      treated with ECMO.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>up to 28 days</time_frame>
    <description>mortality after ICH/no ICH in ARDS patients with ECMO</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>up to 28 days</time_frame>
    <description>days on ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilator/ECMO-free days</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Ventilator/ECMO-free days</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>ARDS, Human</condition>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <arm_group>
    <arm_group_label>intracranial hemorrhage (ICH)</arm_group_label>
    <description>ARDS patients treated with ECMO developing ICH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no intracranial hemorrhage</arm_group_label>
    <description>ARDS patients treated with ECMO not developing ICH</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>complication versus no complication</intervention_name>
    <description>development of ICH</description>
    <arm_group_label>intracranial hemorrhage (ICH)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill patients on the ICU with acute lung failure (ARDS) in a German regional ARDS
        referral center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ARDS following Berlin definition (mild, moderate, severe)

          -  ECMO therapy (veno-venous cannulation)

        Exclusion Criteria:

          -  ECMO, other than VV

          -  ICH at initiation of ECMO

          -  no cerebral CT scan at any time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mario Menk, PD Dr med</last_name>
    <phone>+4930450551002</phone>
    <email>mario.menk@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charite university medicine Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Menk, PD Dr med</last_name>
      <phone>+4930450551002</phone>
      <email>mario.menk@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Oliver Hunsicker, Dr med</last_name>
      <phone>+4930450551002</phone>
      <email>oliver.hunsicker@charite.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>October 26, 2019</last_update_submitted>
  <last_update_submitted_qc>October 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Mario Menk</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

